Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Erschienen in: psychopraxis. neuropraxis 2/2017

01.04.2017 | Psychiatrie

Schizophrenie und somatische Komorbiditäten

verfasst von: Prim. Assoc. Prof. Priv.-Doz. Dr. Martin Aigner

Erschienen in: psychopraxis. neuropraxis | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten
share
TEILEN

Zusammenfassung

Patienten mit Schizophrenie leiden häufiger an körperlichen Erkrankungen und haben auch eine geringere Lebenserwartung. Die Körperlichen Erkranken bei Schizophrenie ziehen sich über ein breites Spektrum: metabolisches Syndrom, Diabetes mellitus, kardiale Herzkrankheit, polyzystisches Ovarsyndrom, Knochenbrüche und schlechterer Zahnstatus. Hinsichtlich der rheumatoiden Arthritis dürfte aber ein „Schutz“ bestehen. Bezüglich der ätiologischen Faktoren wird von der Vulnerabilität, dem Lifestyle, Medikamenten und anderen psychotropen Substanzen ebenfalls eine breite Palette diskutiert. Insbesondere hinsichtlich des Immunsystems dürfte es hier vielversprechende neue Ansätze geben. Jedenfalls erscheint es wichtig, die somatischen Komorbiditäten der Schizophrenie in die Behandlungskonzepte mit einzubeziehen, um für diese Patientengruppe ein besseres Behandlungs- und Therapieangebot stellen zu können.
Literatur
1.
Zurück zum Zitat Ward MC, White DT, Druss BG (2015) A meta-review of lifestyle interventions for cardiovascular risk factors in the general medical population: lessons for individuals with serious mental illness. J Clin Psychiatry 76:e477–e486 CrossRefPubMed Ward MC, White DT, Druss BG (2015) A meta-review of lifestyle interventions for cardiovascular risk factors in the general medical population: lessons for individuals with serious mental illness. J Clin Psychiatry 76:e477–e486 CrossRefPubMed
2.
Zurück zum Zitat Bartoli F, Crocamo C, Caslini M, Clerici M, Carrà G (2015) Schizoaffective disorder and metabolic syndrome: a meta-analytic comparison with schizophrenia and other non-affective psychoses. J Psychiatr Res 66-67:127–134 CrossRefPubMed Bartoli F, Crocamo C, Caslini M, Clerici M, Carrà G (2015) Schizoaffective disorder and metabolic syndrome: a meta-analytic comparison with schizophrenia and other non-affective psychoses. J Psychiatr Res 66-67:127–134 CrossRefPubMed
3.
Zurück zum Zitat Stubbs B, Thompson T, Acaster S, Vancampfort D, Gaughran F, Correll CU (2015b) Decreased pain sensitivity among people with schizophrenia: a meta-analysis of experimental pain induction studies. Pain 156:2121–2131 CrossRefPubMed Stubbs B, Thompson T, Acaster S, Vancampfort D, Gaughran F, Correll CU (2015b) Decreased pain sensitivity among people with schizophrenia: a meta-analysis of experimental pain induction studies. Pain 156:2121–2131 CrossRefPubMed
4.
Zurück zum Zitat Fernández-San-Martín MI, Martín-López LM, Masa-Font R, Olona-Tabueña N, Roman Y, Martin-Royo J, Oller-Canet S, González-Tejón S, San-Emeterio L, Barroso-Garcia A, Viñas-Cabrera L, Flores-Mateo G (2014) The effectiveness of lifestyle interventions to reduce cardiovascular risk in patients with severe mental disorders: meta-analysis of intervention studies. Community Ment Health J 50:81–95 CrossRefPubMed Fernández-San-Martín MI, Martín-López LM, Masa-Font R, Olona-Tabueña N, Roman Y, Martin-Royo J, Oller-Canet S, González-Tejón S, San-Emeterio L, Barroso-Garcia A, Viñas-Cabrera L, Flores-Mateo G (2014) The effectiveness of lifestyle interventions to reduce cardiovascular risk in patients with severe mental disorders: meta-analysis of intervention studies. Community Ment Health J 50:81–95 CrossRefPubMed
5.
Zurück zum Zitat Euesden J, Breen G, Farmer A, McGuffin P, Lewis CM (2015) The relationship between schizophrenia and rheumatoid arthritis revisited: genetic and epidemiological analyses. Am J Med Genet B Neuropsychiatr Genet 168B(2):81–88 CrossRefPubMed Euesden J, Breen G, Farmer A, McGuffin P, Lewis CM (2015) The relationship between schizophrenia and rheumatoid arthritis revisited: genetic and epidemiological analyses. Am J Med Genet B Neuropsychiatr Genet 168B(2):81–88 CrossRefPubMed
6.
Zurück zum Zitat de Campos-Carli SM, Araújo MS, de Oliveira Silveira AC, de Rezende VB, Rocha NP, Ferretjans R, Ribeiro-Santos R, Teixeira-Carvalho A, Martins-Filho OA, Berk M, Salgado JV, Teixeira AL (2016) Cannabinoid receptors on peripheral leukocytes from patients with schizophrenia: evidence for defective immunomodulatory mechanisms. J Psychiatr Res 87:44–52 CrossRefPubMed de Campos-Carli SM, Araújo MS, de Oliveira Silveira AC, de Rezende VB, Rocha NP, Ferretjans R, Ribeiro-Santos R, Teixeira-Carvalho A, Martins-Filho OA, Berk M, Salgado JV, Teixeira AL (2016) Cannabinoid receptors on peripheral leukocytes from patients with schizophrenia: evidence for defective immunomodulatory mechanisms. J Psychiatr Res 87:44–52 CrossRefPubMed
7.
Zurück zum Zitat Flinkkilä E, Keski-Rahkonen A, Marttunen M, Raevuori A (2016) Prenatal inflammation, infections and mental disorders. Psychopathology 49:317–333 CrossRefPubMed Flinkkilä E, Keski-Rahkonen A, Marttunen M, Raevuori A (2016) Prenatal inflammation, infections and mental disorders. Psychopathology 49:317–333 CrossRefPubMed
8.
Zurück zum Zitat Erhardt S, Schwieler L, Imbeault S, Engberg G (2017) The kynurenine pathway in schizophrenia and bipolar disorder. Neuropharmacology 112(Pt B):297–306 CrossRefPubMed Erhardt S, Schwieler L, Imbeault S, Engberg G (2017) The kynurenine pathway in schizophrenia and bipolar disorder. Neuropharmacology 112(Pt B):297–306 CrossRefPubMed
9.
Zurück zum Zitat Weinberg SM, Jenkins EA, Marazita ML, Maher BS (2007) Minor physical anomalies in schizophrenia: a meta-analysis. Schizophr Res 89(1–3):72–85 CrossRefPubMed Weinberg SM, Jenkins EA, Marazita ML, Maher BS (2007) Minor physical anomalies in schizophrenia: a meta-analysis. Schizophr Res 89(1–3):72–85 CrossRefPubMed
10.
Zurück zum Zitat Grover S, Nebhinani N, Padmavati R, Chadda RK, Tirupati S, Pallava A (2015) Metabolic syndrome in antipsychotic naïve patients with schizophrenia: pooled analysis of data from three Indian studies. Early Interv Psychiatry 9:357–362 CrossRefPubMed Grover S, Nebhinani N, Padmavati R, Chadda RK, Tirupati S, Pallava A (2015) Metabolic syndrome in antipsychotic naïve patients with schizophrenia: pooled analysis of data from three Indian studies. Early Interv Psychiatry 9:357–362 CrossRefPubMed
11.
Zurück zum Zitat Reddy SM, Goudie CT, Agius M (2013) The metabolic syndrome in untreated schizophrenia patients: prevalence and putative mechanisms. Psychiatr Danub 25(Suppl 2):S94–S98 PubMed Reddy SM, Goudie CT, Agius M (2013) The metabolic syndrome in untreated schizophrenia patients: prevalence and putative mechanisms. Psychiatr Danub 25(Suppl 2):S94–S98 PubMed
12.
Zurück zum Zitat Mitchell AJ, Vancampfort D, Sweers K, van Winkel R, Yu W, De Hert M (2013) Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders – a systematic review and meta-analysis. Schizophr Bull 39:306–318 CrossRefPubMed Mitchell AJ, Vancampfort D, Sweers K, van Winkel R, Yu W, De Hert M (2013) Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders – a systematic review and meta-analysis. Schizophr Bull 39:306–318 CrossRefPubMed
13.
Zurück zum Zitat Mitchell AJ, Lord O (2010) Do deficits in cardiac care influence high mortality rates in schizophrenia? A systematic review and pooled analysis. J Psychopharmacol (Oxford) 24(4 Suppl):69–80 CrossRef Mitchell AJ, Lord O (2010) Do deficits in cardiac care influence high mortality rates in schizophrenia? A systematic review and pooled analysis. J Psychopharmacol (Oxford) 24(4 Suppl):69–80 CrossRef
14.
Zurück zum Zitat Mitchell AJ, Lawrence D (2011) Revascularisation and mortality rates following acute coronary syndromes in people with severe mental illness: comparative meta-analysis. Br J Psychiatry 198:434–441 CrossRefPubMed Mitchell AJ, Lawrence D (2011) Revascularisation and mortality rates following acute coronary syndromes in people with severe mental illness: comparative meta-analysis. Br J Psychiatry 198:434–441 CrossRefPubMed
16.
Zurück zum Zitat Klemettilä JP, Kampman O, Seppälä N, Viikki M, Hämäläinen M, Moilanen E, Leinonen E (2016) Resistin as an inflammatory marker in patients with schizophrenia treated with clozapine. Nord J Psychiatry 23:1–7 Klemettilä JP, Kampman O, Seppälä N, Viikki M, Hämäläinen M, Moilanen E, Leinonen E (2016) Resistin as an inflammatory marker in patients with schizophrenia treated with clozapine. Nord J Psychiatry 23:1–7
17.
Zurück zum Zitat Tourjman V, Kouassi É, Koué MÈ, Rocchetti M, Fortin-Fournier S, Fusar-Poli P, Potvin S (2013) Antipsychotics’ effects on blood levels of cytokines in schizophrenia: a meta-analysis. Schizophr Res 151:43–47 CrossRefPubMed Tourjman V, Kouassi É, Koué MÈ, Rocchetti M, Fortin-Fournier S, Fusar-Poli P, Potvin S (2013) Antipsychotics’ effects on blood levels of cytokines in schizophrenia: a meta-analysis. Schizophr Res 151:43–47 CrossRefPubMed
18.
Zurück zum Zitat Catts VS, Catts SV, O’Toole BI, Frost AD (2008) Cancer incidence in patients with schizophrenia and their first-degree relatives–a meta-analysis. Acta Psychiatr Scand 117:323–336 CrossRefPubMed Catts VS, Catts SV, O’Toole BI, Frost AD (2008) Cancer incidence in patients with schizophrenia and their first-degree relatives–a meta-analysis. Acta Psychiatr Scand 117:323–336 CrossRefPubMed
19.
Zurück zum Zitat De Hert M, Peuskens J, Sabbe T, Mitchell AJ, Stubbs B, Neven P, Wildiers H, Detraux J (2016) Relationship between prolactin, breast cancer risk, and antipsychotics in patients with schizophrenia: a critical review. Acta Psychiatr Scand 133:5–22 CrossRefPubMed De Hert M, Peuskens J, Sabbe T, Mitchell AJ, Stubbs B, Neven P, Wildiers H, Detraux J (2016) Relationship between prolactin, breast cancer risk, and antipsychotics in patients with schizophrenia: a critical review. Acta Psychiatr Scand 133:5–22 CrossRefPubMed
20.
Zurück zum Zitat Catalá-López F, Suárez-Pinilla M, Suárez-Pinilla P, Valderas JM, Gómez-Beneyto M, Martinez S, Balanzá-Martínez V, Climent J, Valencia A, McGrath J, Crespo-Facorro B, Sanchez-Moreno J, Vieta E, Tabarés-Seisdedos R (2014) Inverse and direct cancer comorbidity in people with central nervous system disorders: a meta-analysis of cancer incidence in 577,013 participants of 50 observational studies. Psychother Psychosom 83:89–105 CrossRefPubMed Catalá-López F, Suárez-Pinilla M, Suárez-Pinilla P, Valderas JM, Gómez-Beneyto M, Martinez S, Balanzá-Martínez V, Climent J, Valencia A, McGrath J, Crespo-Facorro B, Sanchez-Moreno J, Vieta E, Tabarés-Seisdedos R (2014) Inverse and direct cancer comorbidity in people with central nervous system disorders: a meta-analysis of cancer incidence in 577,013 participants of 50 observational studies. Psychother Psychosom 83:89–105 CrossRefPubMed
21.
Zurück zum Zitat Matevosyan NR (2011) Schizophrenia and Stein-Leventhal syndrome: comorbidity features. Arch Gynecol Obstet 284:1035–1041 CrossRefPubMed Matevosyan NR (2011) Schizophrenia and Stein-Leventhal syndrome: comorbidity features. Arch Gynecol Obstet 284:1035–1041 CrossRefPubMed
22.
Zurück zum Zitat Stubbs B, Gaughran F, Mitchell AJ, De Hert M, Farmer R, Soundy A, Rosenbaum S, Vancampfort D (2015a) Schizophrenia and the risk of fractures: a systematic review and comparative meta-analysis. Gen Hosp Psychiatry 37:126–133 CrossRefPubMed Stubbs B, Gaughran F, Mitchell AJ, De Hert M, Farmer R, Soundy A, Rosenbaum S, Vancampfort D (2015a) Schizophrenia and the risk of fractures: a systematic review and comparative meta-analysis. Gen Hosp Psychiatry 37:126–133 CrossRefPubMed
23.
Zurück zum Zitat Endres D, Dersch R, Stich O, Buchwald A, Perlov E, Feige B, Maier S, Riedel A, van Elst LT (2016) Vitamin D deficiency in adult patients with schizophreniform and autism spectrum syndromes: a one-year cohort study at a German tertiary care hospital. Front Psychiatry 7:168 PubMedPubMedCentral Endres D, Dersch R, Stich O, Buchwald A, Perlov E, Feige B, Maier S, Riedel A, van Elst LT (2016) Vitamin D deficiency in adult patients with schizophreniform and autism spectrum syndromes: a one-year cohort study at a German tertiary care hospital. Front Psychiatry 7:168 PubMedPubMedCentral
24.
Zurück zum Zitat Moore S, Shiers D, Daly B, Mitchell AJ, Gaughran F (2015) Promoting physical health for people with schizophrenia by reducing disparities in medical and dental care. Acta Psychiatr Scand 132:109–121 CrossRefPubMed Moore S, Shiers D, Daly B, Mitchell AJ, Gaughran F (2015) Promoting physical health for people with schizophrenia by reducing disparities in medical and dental care. Acta Psychiatr Scand 132:109–121 CrossRefPubMed
Metadaten
Titel
Schizophrenie und somatische Komorbiditäten
verfasst von
Prim. Assoc. Prof. Priv.-Doz. Dr. Martin Aigner
Publikationsdatum
01.04.2017
Verlag
Springer Vienna
Erschienen in
psychopraxis. neuropraxis / Ausgabe 2/2017
Print ISSN: 2197-9707
Elektronische ISSN: 2197-9715
DOI
https://doi.org/10.1007/s00739-017-0375-9